Iridex to Report Second Quarter 2021 Financial Results on August 12, 2021

Rhea-AI Summary

Iridex Corporation (NASDAQ: IRIX), based in Mountain View, California, plans to release its financial results for Q2 2021 on August 12, 2021, after market close. The management team will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss the results. Investors can join the call by dialing (844) 707-0665 domestically or (703) 326-3030 internationally, using conference ID: 9257308. A live and archived webcast will also be available on Iridex's website.

Positive

• Company prepares to announce future financial results, indicating ongoing operations.
• Management engagement through a scheduled conference call shows transparency and investor communication.

Negative

• None.

MOUNTAIN VIEW, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the second quarter of 2021 after the close of trading on Thursday, August 12, 2021. The Company’s management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET.

Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for international callers, using conference ID: 9257308. A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at: www.iridex.com.

About Iridex
Iridex is a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma, diabetic macular edema and other retinal diseases. Iridex products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit www.iridex.com.

Investor Relations Contact:
Leigh Salvo
(415) 937-5404
investors@iridex.com

FAQ

When will Iridex Corporation release its Q2 2021 financial results?

Iridex Corporation will release Q2 2021 financial results on August 12, 2021, after market close.

What time is the conference call for Iridex's Q2 2021 results?

The conference call for Iridex's Q2 2021 results is scheduled for 2:00 p.m. PT / 5:00 p.m. ET.

How can I listen to the Iridex conference call?

You can listen to the Iridex conference call by dialing (844) 707-0665 for domestic calls or (703) 326-3030 for international calls, using conference ID: 9257308.

Is there a webcast available for the Iridex conference call?

Yes, a live and archived webcast of the Iridex conference call will be available on the company's website.